ES2426441T3 - Oligopéptidos y su uso en cosméticos - Google Patents

Oligopéptidos y su uso en cosméticos Download PDF

Info

Publication number
ES2426441T3
ES2426441T3 ES05798576T ES05798576T ES2426441T3 ES 2426441 T3 ES2426441 T3 ES 2426441T3 ES 05798576 T ES05798576 T ES 05798576T ES 05798576 T ES05798576 T ES 05798576T ES 2426441 T3 ES2426441 T3 ES 2426441T3
Authority
ES
Spain
Prior art keywords
group
saturated
pro
unsaturated
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05798576T
Other languages
English (en)
Spanish (es)
Inventor
Philippe Moussou
Louis Danoux
Gilles Pauly
Jean-Luc Contet-Audonneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS, Cognis France SAS filed Critical BASF Beauty Care Solutions France SAS
Application granted granted Critical
Publication of ES2426441T3 publication Critical patent/ES2426441T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
ES05798576T 2004-10-18 2005-10-10 Oligopéptidos y su uso en cosméticos Expired - Lifetime ES2426441T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292475 2004-10-18
EP04292475 2004-10-18
PCT/EP2005/010893 WO2006042661A2 (en) 2004-10-18 2005-10-10 Oligopeptides and their use in cosmetics

Publications (1)

Publication Number Publication Date
ES2426441T3 true ES2426441T3 (es) 2013-10-23

Family

ID=34931464

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05798576T Expired - Lifetime ES2426441T3 (es) 2004-10-18 2005-10-10 Oligopéptidos y su uso en cosméticos

Country Status (6)

Country Link
US (2) US8044028B2 (cg-RX-API-DMAC10.html)
EP (1) EP1802655B1 (cg-RX-API-DMAC10.html)
JP (1) JP5159311B2 (cg-RX-API-DMAC10.html)
KR (1) KR101264441B1 (cg-RX-API-DMAC10.html)
ES (1) ES2426441T3 (cg-RX-API-DMAC10.html)
WO (1) WO2006042661A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802655B1 (en) 2004-10-18 2013-07-24 BASF Beauty Care Solutions S.A.S. Oligopeptides and their use in cosmetics
PL2027152T3 (pl) * 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
JP5789901B2 (ja) * 2008-05-29 2015-10-07 セラピューティック・ペプタイズ・インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃ Ｐｅｐｔｉｄｅｓ，Ｉｎｃ． 皮膚化粧用組成物におけるオリゴマーバイオサーファクタント
RU2411248C2 (ru) * 2008-11-13 2011-02-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Средство, обладающее антипсихотической активностью
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
WO2011126054A1 (ja) * 2010-04-07 2011-10-13 国立大学法人京都大学 生理活性ペプチド
BR112013013085B1 (pt) 2010-12-07 2018-02-14 Unilever N.V. Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição
EA024551B1 (ru) 2011-11-03 2016-09-30 Юнилевер Н.В. Индивидуальная композиция для очищения
WO2013064633A1 (de) * 2011-11-04 2013-05-10 Amp-Therapeutics Gmbh Oncopeltus-peptidderivate als antimikrobielle peptide
FR3012811B1 (fr) * 2013-11-05 2015-12-25 Basf Beauty Care Solutions France Sas Oligopeptides et leurs utilisations
KR101851236B1 (ko) 2015-07-06 2018-04-24 김철군 동충하초 재배용 배지조성물 및 동충하초 재배방법
KR20190065916A (ko) 2017-12-04 2019-06-12 김철군 동충하초 재배용 배지조성물 및 동충하초의 재배방법
EP3906013A1 (en) 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
KR102192471B1 (ko) * 2019-10-18 2020-12-17 주식회사 인코스팜 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물
KR102952819B1 (ko) * 2022-11-11 2026-04-16 웰펩 주식회사 피부세포 재생 효과가 우수한 펩타이드 및 이를 포함하는 피부세포 재생 촉진용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (cg-RX-API-DMAC10.html) 1973-11-30 1975-08-20
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US6713605B1 (en) 1996-04-10 2004-03-30 Kansas State University Research Foundation Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes
US5830993A (en) 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
US6231768B1 (en) 1999-01-19 2001-05-15 Nalco Chemical Company Rheology modification of settled solids in mineral processing
FR2788777B1 (fr) 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
CA2368638A1 (en) * 1999-03-26 2000-10-05 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
CA2388868A1 (en) 1999-10-25 2001-05-03 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
AU2599001A (en) 1999-12-29 2001-07-09 Beth Israel Deaconess Medical Center Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation
ATE510852T1 (de) * 2001-10-30 2011-06-15 Dsm Ip Assets Bv Dermopharmazeutisch und kosmetisch wirksame oligopeptide
WO2003042387A1 (fr) * 2001-11-13 2003-05-22 Keio University Nouvelles proteines associees a la keratine des poils
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
CA2501645A1 (en) * 2002-10-10 2004-04-22 Verenium Corporation Proteases, nucleic acids encoding them and methods for making and using them
EP1802655B1 (en) 2004-10-18 2013-07-24 BASF Beauty Care Solutions S.A.S. Oligopeptides and their use in cosmetics

Also Published As

Publication number Publication date
US8044028B2 (en) 2011-10-25
JP5159311B2 (ja) 2013-03-06
EP1802655B1 (en) 2013-07-24
JP2008517009A (ja) 2008-05-22
KR101264441B1 (ko) 2013-05-14
KR20070065882A (ko) 2007-06-25
US20100137560A1 (en) 2010-06-03
EP1802655A2 (en) 2007-07-04
WO2006042661A3 (en) 2006-07-27
WO2006042661A2 (en) 2006-04-27
US20120172308A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
US20120172308A1 (en) Oligopeptides And Their Use In Cosmetics
US8815814B2 (en) Cosmetic composition containing oligopeptides
US8399415B2 (en) Oligopeptides and cosmetic compositions containing the oligopeptides
ES2334102T3 (es) Uso de extractos del hongo grifola frondosa.
US20100183527A1 (en) Cosmetic Compositions Comprising Sclareolide and Hesperidin Methyl Chalcone
ES2347955T3 (es) Utilización de un extracto de la planta vigna aconitifolia en una composición cosmética y/o farmacéutica dermatológica.
US20240041743A1 (en) Synergistic tetrapeptide combination
US20030068364A1 (en) Pro-liposomal encapsulated preparations (iv)
CN113264984A (zh) 肽化合物、包含它们的组合物和所述化合物，特别是化妆品的用途
KR101240695B1 (ko) Ｐｔｈ 단편 함유 화장품 제제
JP2003531844A (ja) 植物Ａｒｇａｎｉａｓｐｉｎｏｓａの抽出物を含有する化粧品製剤および／または医薬製剤
US20030170298A1 (en) Proliposomal encapsulated preparations
ES2250188T3 (es) Preparados cosmeticos y/o farmaceuticos.
FR3012811A1 (fr) Oligopeptides et leurs utilisations